Key result
Transcatheter aortic valve replacement was associated with higher 5-year all-cause mortality than surgical aortic valve replacement in matched patients.
Why the study?
Does isolated transfemoral TAVR improve 5-year all-cause mortality compared to isolated SAVR in low-risk patients with aortic valve stenosis?
Does isolated transfemoral TAVR improve 5-year all-cause mortality compared to isolated SAVR in low-risk patients with aortic valve stenosis?
Answers are grounded in this paper and cite their sources.
This editorial highlights observational data showing superior 5-year survival with SAVR over TAVR in low-risk aortic stenosis patients, emphasizing the need for further high-quality studies accounting for frailty and unmeasured confounders as well as judicious multidisciplinary Heart Team decision-making.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Biancari et al. (2024) conducted an editorial in Aortic valve stenosis. Isolated transfemoral transcatheter aortic valve replacement (TAVR) vs. Isolated surgical aortic valve replacement (SAVR) with a Perimount bioprosthesis was evaluated on 5-year all-cause mortality (HR 2.05, 95% CI 1.55-2.71). Transcatheter aortic valve replacement was associated with higher 5-year all-cause mortality than surgical aortic valve replacement in matched patients.
Synapse has enriched 10 related papers. Consider them for comparative context: